Arab Finance: Macro Group Pharmaceutical (Macro Capital) announced that it is targeting sales of EGP 1 billion in 2023 by maintaining the 25-30% expected growth rate this year, as per a filing on April 10th.
The company posted a 17.51% year-on-year (YoY) increase in its consolidated net profits after tax and non-controlling interests during the full year ended December 31st 2022.
Founded in 2002, Macro Group is a leading Egyptian cosmeceutical company based in Cairo.